Anti-mouse CD4-InVivo

製品コード:A2101         Batch: A210126

印刷

Anti-mouse CD4 antibody(Clone:GK1.5) reacts with mouse CD4, which is a 55 kDa cell surface type I membrane glycoprotein. CD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting cells.

製品説明

Formulation PBS buffer, pH 6.5
Clone GK1.5
Immunogen

Mouse CTL clone V4

Isotype Rat IgG2b,κ
Application In vivo CD4+ T cell depletion,FCM,WB
Source CHO
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Sterility 0.2 μM filtered
Purity 99%
Protein concentration 7.45 mg/ml
Endotoxin Level <1EU/mg

カスタマーフィードバック

A2101  Anti-mouse CD4-InVivo-1.gif

A2101  Anti-mouse CD4-InVivo.gif

A2101-Anti-mouse-CD4-InVivo-5.gif

A2101  Anti-mouse CD4-InVivo-2.gif

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering [ Journal for ImmunoTherapy of Cancer, March 30, 2026, e014185] PubMed: 41912269
Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC [ Advanced Science, March 12, 2026, e21931] PubMed: 41818612
HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering [ Journal for ImmunoTherapy of Cancer, March 1, 2026, e014185] PubMed: 41912269
DADA Enhances CD8+ T Cell Stemness to Improve Anti‐Tumor Immunity and Immunotherapy Efficacy [ Advanced Science, February 27, 2026, e19765] PubMed: 41758776
Oncolytic adenovirus delivery of neoantigens sensitizes low-mutation tumors to anti-PD-1 therapy and prevents metastasis [ Signal Transduction and Targeted Therapy, December 23, 2025, 410] PubMed: 41429778
Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduct Target Ther, 2025, 10(1):161] PubMed: 40374605
LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation [ Cell Discov, 2025, 11(1):84] PubMed: 41162356
Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy [ Nat Commun, 2025, 10.1038/s41467-025-66630-x] PubMed: 41290746
Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity [ Nat Commun, 2025, 16(1):3546] PubMed: 40229277
BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma [ Cell Rep Med, 2025, 6(3):101995] PubMed: 40107246

人間や獣医の診断であるか治療的な使用のためにでない。